Aspire IRB has named Jon Holmlund, MD, medical director. As medical director, Holmlund is responsible for providing medical and scientific expertise and leadership to ensure the protection of people participating in human research studies reviewed and overseen by Aspire. 

Prior to joining Aspire, Holmlund served as an independent consultant to the biopharmaceutical industry. He has over two decades of experience in medical oncology and cancer therapeutics studies.

"Dr. Holmlund's background is a complementary blend of clinical research and administrative experience," said Alycia Huston, CEO of Aspire. "We're thrilled to have him onboard, and know that we'll benefit from his accomplished background and clear passion for ethics and subject safety."